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Cigarettes kill over 6 million people each year 
– almost twice that from HIV and tuberculosis 
combined.[1] Smoking is strongly associated with 
the five leading causes of global mortality, namely 
ischaemic heart disease, stroke, chronic obstructive 
pulmonary disease, lower respiratory tract infection and lung cancer.
[2] It is estimated that without tobacco, one-third of all cancer deaths 
would be avoided.[3] Yet, despite this overwhelming evidence of 
harm – not to mention financial burden – the majority of smokers 
are unable to quit. The cigarette’s combination of chemical and 
psychological addiction overwhelms common sense; in smoking-
cessation trials, where only highly motivated patients are enrolled, 
sustained quit rates rarely exceed 25%.[4] We need more strings to our 
bow, if we hope to win this battle. Could e-cigarettes play a role in 
smoking cessation? The argument in favour of physicians supporting 
the use and sale of e-cigarettes is simple: they are safer than cigarettes, 
they are effective in reducing tobacco risk and, potentially, they are 
the best method of assisting smokers to quit. 
Although many South African doctors are not familiar with 
e-cigarettes, they already boast 2.5 million users in the US alone and 
have been on the market for almost 10 years. E-cigarettes are battery-
powered devices, similar in appearance to conventional cigarettes 
that vaporise nicotine for inhalation. There is great public interest in 
this product. Google search volumes for ‘e-cigarettes’ have exceeded 
those for both nicotine replacement therapy (NRT) (e.g. gum) and 
varenicline for the last 2 years.[5]
Many smokers have embraced e-cigarettes as an acceptable 
alternative. Users feel that they are a healthier, cheaper substitute for 
tobacco and purchase them primarily to help quit smoking or avoid 
relapse (77% of 3 587 internet responders).[6] The emerging data 
on efficacy are encouraging; e-cigarettes may reduce health risks of 
smokers. One key randomised clinical trial, performed in smokers who 
were not motivated to quit, showed sustained quit rates similar to those 
in motivated populations using trial interventions (e.g. varenicline). 
Without any form of counselling or incentive, quit rates at 1-year 
were 8.7%, with a further 10.3% having >50% reduction in smoking. 
Moreover, 73% of those who gave up smoking at 1 year had quit the 
use of e-cigarettes as well.[7] Perhaps even more impressive is a second 
smaller study using e-cigarettes in schizophrenic patients who had 
no intention of quitting. In this highly addicted group, 64% of study 
participants achieved either abstinence (14% of subjects) or a sustained 
50% reduction in cigarette smoking (in 50% of subjects), at 1 year.[8] 
Naturally, the question of safety arises. The main components 
of the refill fluid are nicotine, the vaporising propellant (propylene 
glycol or vegetable glycerin) and chemicals used as flavourants. They 
do not produce smoke, but a vapour that is inhaled, and the common 
adverse effects of e-cigarettes (cough, mouth irritation and headache) 
are mild and appear to decrease over time.[7] The nicotine component 
of e-cigarettes is thought to be safe as it has not been shown to cause 
cancer, cardiovascular disease or lung damage [9] – neither has it been 
shown to be cytotoxic to stem cells.[10] An additional advantage is that 
e-cigarettes are not associated with side-stream smoking – they have 
not been shown to affect bystanders, which could potentially reduce 
the 600 000 annual deaths associated with passive smoking. [1,11] A 
further advantage of their use is that switching is not associated 
with the weight gain seen in smokers who quit. But the real benefit 
for those who convert is the sparing of exposure to the over 8 000 
chemicals (including carcinogens) found in cigarette smoke. It is 
highly unlikely that e-cigarettes are as toxic to human tissues as 
conventional cigarettes. In support of this, e-cigarettes do not result 
in the acute rise in white blood cells or carbon monoxide levels 
seen with conventional cigarettes.[7,11] The reduction in exposure to 
innumerable carcinogens, with the long-term reduction in risk of 
numerous cancers, is likely to prove the e-cigarette’s greatest benefit. 
E-cigarettes are used as NRT to overcome the unpleasant cravings 
of nicotine withdrawal. Although not as effective as cigarettes, they 
are more efficient than other forms of NRT in their ability to deliver 
nicotine.[12] Thus they alleviate the desire to smoke, and most users 
surveyed report being able to cut back successfully on tobacco and 
believe that e-cigarettes helped them to achieve smoking cessation. [12,13] 
Uniquely, e-cigarettes address the psychological and social aspects 
of smoking that bind many people to the habit by allowing potential 
quitters to participate in the ‘ritual’ of smoking.[7] The flavouring of 
e-cigarettes (including tobacco, blackberry, vanilla and even ‘red-bull’ 
flavour) provides an exciting, socially acceptable alternative to cigarettes. 
It is estimated that smoking cessation before the age of 45 years adds, 
on average, 9 years to a person’s life.[14] In light of this, if e-cigarettes 
improve quit rates, surely they should be considered, if not embraced.
They remain the only currently available therapy that simultaneously 
addresses both the physical and psychological components of tobacco 
addiction – assisting smokers to both quit and cut down, with the 
added benefit of avoiding ‘passive smoking’ by others. 
E-cigarettes are safe and effective and, based on the available 
evidence, the potential benefits must outweigh their risks, especially 
when compared with the alternative: smoking.
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Electronic cigarettes (e-cigarettes) are relatively new in South Africa and their popularity is increasing. Their appearance coincides with 
intensifying attempts by government and society to reduce tobacco smoking through stricter limitation on its sale, advertising and use. 
Debate has been triggered on their use regarding the potential risks of increasing nicotine addiction and encouraging people to start 
smoking, or whether e-cigarettes might serve rather as an efficient means of treating addiction, thus assisting smokers to quit. 
Opinions among doctors regarding e-cigarettes vary, some seeing potential for good, others condemning them outright. Several 
professional medical societies have taken the stand that, whatever their potential as a smoking-cessation method, they cannot be encouraged 
since they are produced and promoted by the tobacco industry. Also, that research supported by the manufacturers of e-cigarettes may not 
be presented at their meetings or in their medical journals. 
We present the following arguments for the potential benefit and harms of e-cigarettes, based on the currently available evidence.
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